SAN FRANCISCO, Oct. 17 – Applied Biosytems and SurroMed jointly received a three-year $8 million grant from the National Institute of Standards and Technology Advanced Technology Program, the companies announced Wednesday.

The grant is for the development of Mountain View, Calif.-based SurroMed's nanoscale technology and Foster City, Calif.-based Applied Biosystems' multiplexing chemistry capabilities for DNA analysis. $3.7 million is slated for SurroMed and $4.3 million for Applied Biosystems, according to the companies.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Helix customers can purchase apps that interpret different aspects of their genome, Technology Review reports.

The New York Times reports that a number of companies and research institutes are pursuing gene therapies.

Salmon with shorter telomeres survive to make the trip back to their river homes, New Scientist reports.

In PLOS this week: vaginal microbiome composition, population patterns of Chagas-carrying Rhodnius ecuadoriensis, and more.